Χώρα: Ταϊβάν
Γλώσσα: Κινεζικά
Πηγή: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
AXITINIB
輝瑞大藥廠股份有限公司 台北市信義區松仁路100號42、43樓 (37199708)
L01EK01
膜衣錠
AXITINIB (1013003200) MG
鋁箔盒裝;;塑膠瓶裝
製 劑
須由醫師處方使用
PFIZER MANUFACTURING DEUTSCHLAND GMBH BETRIEBSSTATTE FREIBURG, MOOSWALDALLEE 1, 79090 FREIBURG, GERMANY DE
axitinib
治療已接受過sunitinib或cytokine治療失敗的晚期腎細胞癌病患。
有效日期: 2027/11/13; 英文品名: INLYTA Film-Coated Tablets 1 mg
2012-11-13
1 INLYTA sunitinib cytokine ( RCC ) 2 2.1 INLYTA 5 12 INLYTA 12.3 INLYTA 2.2 5 INLYTA 2 ( [ CTCAE ] ) 7 7 INLYTA 10 INLYTA ( ) INLYTA 5 5 3 2 CYP3A4/5 INLYTA CYP3A4/5 ( ketoconazole itraconazole clarithromycin atazanavir indinavir nefazodone nelfinavir ritonavir saquinavir telithromycin voriconazole ) CYP3A4/5 CYP3A4/5 CYP3A4/5 INLYTA CYP3A4/5 INLYTA axitinib ( AUC ) INLYTA ( 3-5 ) CYP3A4/5 7.1 12.3 ( Child-Pugh A ) INLYTA ( Child-Pugh B ) INLYTA ( Child-Pugh C ) INLYTA 5.12 8.6 12.3 3 INLYTA 1 Pfizer 1 XNB INLYTA 5 Pfizer 5 XNB 4 5 5.1 INLYTA RCC 145/359 ( 40% ) INLYTA 103/355 ( 29% ) sorafenib 56/359 ( 16% ) INLYTA 39/355 ( 11% ) sorafenib 3/4 2/359 ( < 1% ) INLYTA sorafenib ( > 150 mmHg > 100 mmHg ) INLYTA INLYTA 4 1/359 ( < 1% ) INLYTA INLYTA sorafenib 6.1 INLYTA INLYTA INLYTA INLYTA INLYTA INLYTA 2.2 5.2 ( ) INLYTA RCC 4/359 ( 1% ) INLYTA 4/355 ( 1% ) sorafenib 3/4 1/359 ( < 1% ) INLYTA sorafenib 6.1 INLYTA 17/715 ( 2% ) ( ) 2 INLYTA 12 INLYTA 5.3 ( ) INLYTA RCC 11/359 ( 3% ) INLYTA 2/355 ( 1% ) sorafenib 9/359 ( 3% ) INLYTA 2/355 ( 1% ) sorafenib 3/4 ( ) 1/359 ( < 1% ) INLYTA sorafenib INLYTA 22/715 ( 3% ) INLYTA 6 INLYTA 5.4 INLYTA RCC 58/359 ( 16% ) INLYTA 64/355 ( 18% ) sorafenib INLYTA ( 6% ) ( 3% ) ( 2% ) ( 2% ) 5/359 ( 1% ) INLYTA 11/355 ( 3% ) sorafenib 3/4 ( ) 1/359 ( < 1% ) INLYTA ( ) 3/355 ( 1% ) sorafenib INLYTA INLYTA 5.5 INLYTA RCC INLYTA 6/359 ( 2% ) sorafenib 3/355 ( 1% ) INLYTA 2/359 ( 1% ) sorafenib 1/355 ( < 1% ) 3/4 INLYTA 2/359 ( 1% ) sorafenib 1/355 ( < 1% ) INLYTA INLYTA 5.6 INLYTA RCC 1/359 ( < 1% ) INLYTA sorafenib INLYTA 5/715 ( 1% ) 4/715 ( 1% ) INLYTA 5.7 INLYTA RCC 69/359 ( 19% ) INLYTA 29/355 ( 8% ) sorafenib 4/359 ( 1% ) INLYTA 4/355 ( 1% ) sorafenib ( TSH ) < 5 µU/mL 79/245 ( 32% ) INLYTA 25/232 ( 11% ) sorafenib TSH ≥ 10 µU/mL 6.1 INLYTA 5.8 ( VEGF ) INLYTA 2 INLYTA 2 INLYTA INLYTA 5.9 INLYTA RCC 1/359 ( < 1% ) INLYTA ( RPLS ) sorafenib 6.1 INLYTA RPLS RPLS RPLS RPLS INLYTA RPLS INLYTA 5.10 INLYTA RCC 39/359 ( 11% ) INLYTA 26/355 ( 7% ) sorafenib 11/359 ( 3% ) INLYTA 6/ Διαβάστε το πλήρες έγγραφο